Comparative Evaluation of Radiotherapy with Concurrent Weekly Cisplatin versus Concurrent Daily Erlotinib and Weekly Cisplatin in Locally Advanced Carcinoma Cervix

Journal Title: INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY - Year 2018, Vol 5, Issue 10

Abstract

Background: Erlotinib is an oral epidermal growth factor receptor tyrosine kinase inhibitor. Early phase clinical trials of Erlotinib in combination with cisplatin-based concurrent chemoradiotherapy (CCRT) in locally advanced carcinoma cervix have demonstrated improved antitumor responses with mild toxicity profile; however, the evidence available on this is limited. We prospectively evaluated the efficacy and safety of Erlotinib (150 mg/day) with CCRT in locally advanced carcinoma cervix and compared with standard CRT. Materials and Methods: In this prospective, comparative study, 60 locally advanced carcinoma cervix patients received either Erlotinib (150 mg/day) with CRT or CRT. Treatment CRT included cisplatin 40 mg/m2 intravenously weekly concurrently with external beam radiation followed by intracavitary brachytherapy. Tumor response was calculated as per the WHO criteria. Toxicity and adverse events (AEs) were assessed as per CTCAE v 3. Results: The higher number of patients achieved a complete response in the Erlotinib plus CRT group than the CRT group (28/30, 93.3% vs. 21/30, 70%, P < 0.05), which was statistically significant. The AEs commonly encountered in both the treatment groups were majority of Grade 1/2. A higher incidence of diarrhea and skin reaction was noted in the Erlotinib plus CRT group in comparison CRT, whereas the incidence of nausea and vomiting was higher in the CRT group. No Grades 4 and 5 toxicity was observed in Erlotinib with CRT. Erlotinib was observed to be safe with manageable toxicity profile. Conclusion: Erlotinib 150 mg daily can be safely added to cisplatin-based CCRT in locally advanced carcinoma cervix, to achieve better therapeutic response without potentiating the toxicity

Authors and Affiliations

Shyamji Rawat, M K Advait, Pranjil Mandloi

Keywords

Related Articles

Sutureless and Glueless Amniotic Membrane Graft in Primary Pterygium Surgery

Introduction: Amniotic membrane has a very unique property as it shares the basement membrane properties of conjunctiva. Hence, it is useful replacement for the conjunctiva in pterygium surgery. Objective: The objective...

Knowledge among Primary Health-care Doctor of Screening, Diagnosing, and Management of Prediabetes in Al-Hasa, Saudi Arabia

Background: Prediabetes affects around 3 million KSA adults, but primary health-care (PHC) doctors knowledge, practices, attitudes, and beliefs toward prediabetes are unclear. Objective: The objective of this study was t...

Imaging Characteristics of Focal Liver Lesions on Contrast-Enhanced Helical Computed Tomography

Introduction: The discovery of computed tomography (CT) by G.N. Hounsfield in 1972 has been a milestone in medical diagnostic imaging as cross-sectional imaging took a step into diagnostic radiology. The use of contrast...

A Study of Respiratory Distress in Term Neonates in Early Neonatal Period

introduction: Respiratory distress is one of the most common cause of admission in Neonatal Intensive Care Unit and results from a variety of respiratory and non-respiratory etiologies. It accounts for significant morbid...

Histopathological Profile of Breast Cancer in a Rural Population

Introduction: Breast cancer is the most common malignant tumor. Although the majority of underlying causes and other features are usually uniform worldwide, every region has its own uniqueness for that cancer among femal...

Download PDF file
  • EP ID EP476146
  • DOI -
  • Views 75
  • Downloads 0

How To Cite

Shyamji Rawat, M K Advait, Pranjil Mandloi (2018). Comparative Evaluation of Radiotherapy with Concurrent Weekly Cisplatin versus Concurrent Daily Erlotinib and Weekly Cisplatin in Locally Advanced Carcinoma Cervix. INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 5(10), 48-54. https://europub.co.uk/articles/-A-476146